Agilent Technologies Inc vs iShares Global Clean Energy ETF — how do they compare? Agilent Technologies Inc trades at $149.35 (market cap $42.00B), while iShares Global Clean Energy ETF trades at $18.21. The key difference: Agilent Technologies Inc pays a 0.69% dividend while iShares Global Clean Energy ETF pays none, and Agilent Technologies Inc is trading nearer its 52-week high, iShares Global Clean Energy ETF nearer its low. Which is the better fit depends on your goals.
| A | ICLN | |
|---|---|---|
Market Cap | $42.00B | — |
Sector | Health | — |
52-Week High | $157.20 | $23.75 |
52-Week Low | $110.24 | $13.53 |
Enterprise Value | $43.55B | — |
Dividend Yield | 0.69% | — |
Signals from Pluang's Aura AI — not financial advice
Agilent Technologies (A) trades at $145.97, up 3.28% in the last session, with a bullish technical outlook from moving averages but overbought RSI levels. The company reported strong Q1 2026 earnings, beating estimates with EPS of $1.49, and maintains solid profitability with a net income margin of 19.55%. Recent developments include FDA and EU approvals for diagnostic assays and the acquisition of Biocare Medical, enhancing its healthcare portfolio.
The stock offers upside to the consensus price target of $154.90, supported by analyst optimism (77.5% buy ratings), but high valuation ratios like a P/E of 146.56 pose risks. Investors should monitor execution of growth initiatives and competitive pressures in the life sciences sector, with earnings on August 26, 2026, as a key catalyst.
ICLN trades at $18.30, up 0.99% today, but technical indicators signal a bearish trend with resistance near $19. The ETF lacks key valuation metrics like P/E and P/S due to its structure, and recent news highlights competition from traditional energy ETFs offering higher yields and lower fees. Clean energy faces policy risks, with stalled U.S. permits threatening investment, though global demand for renewables remains strong.
Outlook is cautious; ICLN offers growth exposure to 105 global clean energy firms but underperforms peers on fees and dividends. Risks include regulatory uncertainty and volatility, while analyst sentiment is mixed amid sector comparisons. Investors should weigh long-term green energy trends against near-term headwinds.
Trailing returns across standard periods
Originally spun out of Hewlett-Packard in 1999, Agilent has evolved into a leading life sciences and diagnostics firm. Today, Agilent's measurement technologies serve a broad base of customers with its three operating segments: life science and applied tools (45% of fiscal 2021 sales), cross lab (35% of sales consisting of consumables and services related to its life science and applied tools), and diagnostics and genomics (20%). Over half of its sales are generated from the biopharmaceutical, chemical, and energy end markets, but it also supports clinical lab, environmental, forensics, food, academic, and government-related organizations. The company is geographically diverse, with operations in the U.S. (34%) and China (20%) representing the largest country concentrations.
Read more on A →The index is designed to track the performance of approximately 100 clean energy-related companies. The fund generally invests at least 80% of its assets in the component securities of the target index. The index may invest up to 20% of its assets in certain futures, trading options and swap contracts, cash and cash equivalents, as well as in securities not included in the index. It is non-diversified.
Read more on ICLN →